Pelvic floor symptoms in women losing weight
Part of Digestive system, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how weight-loss treatments affect pelvic floor symptoms (like bladder or bowel issues) in women with obesity. It may help you understand how your weight-loss journey impacts your pelvic health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are female and between 18 and 89 years old.
- Your BMI is 30 or higher (considered obesity).
- You are already getting medical weight-loss care at a Hartford HealthCare clinic (either medication-based or planning bariatric surgery).
- You have a home scale to weigh yourself.
- You are not pregnant, have not had weight-loss surgery before, and do not have active cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether weight-loss surgery can improve urinary symptoms like needing to pee often or suddenly. It is for people with severe obesity who are already being seen at a specific clinic for bariatric surgery.
This study tests a medicine called henagliflozin to see if it helps people with obesity (but not diabetes) lose weight. It is a pill taken by mouth, and the study will compare its effects on weight over time.
This study follows people who recently stopped taking a GLP-1 medication to see how their eating habits, daily routines, and weight change over time. It aims to learn how to better support people after they stop, helping them maintain a healthy weight.
This study looks at how a weight-loss medication affects people with obesity who may have a specific gene difference (caveolin-1). It aims to understand why some people respond differently to GLP-1 treatments like semaglutide.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
Hear when a new Lower Urinary Tract Symptoms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.